We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Making the Move to Continuous Bioprocessing
Making the Move to Continuous Bioprocessing
Blog

Bioprocessing has taken on many forms over the years. Efficiency and process economics are driving the bioprocessing industry forward, fueling a move from traditional stainless steel to single use – and now continuous.

Read More

Designing Proteins Bit by Bit
Designing Proteins Bit by Bit
Blog

Cell-Free Technology is taking a unique approach to protein technology with their BioBits initiative, which they say combines the ease of use of a digital design tool with the detailed scientific validation provided by a CRO. We catch up with Cell-Free CEO Tom Meany to discuss the new technology.

Read More

Developing RNA Medicines for Rare Genetic Diseases
Developing RNA Medicines for Rare Genetic Diseases
Blog

There are approximately 7,000 known rare diseases, however, less than 6% of these have a treatment. It is estimated that between 25–35 million Americans live with a rare disease. The company ProQR is dedicated to developing new therapeutics for patients living with untreated rare diseases. We caught up with Daniel de Boer, Chief Executive Officer at ProQR to learn more about the company’s approach to finding new treatments for rare genetic diseases.

Read More

Benefits of Using 3D Cell Models in Drug Discovery
Benefits of Using 3D Cell Models in Drug Discovery
Blog

As researchers explore therapeutic strategies for more complex and heterogeneous diseases the need for more physiologically relevant models has never been greater. Researchers are increasingly looking to 3D cell cultures, spheroids, organoids and microtissues to bridge the gap between 2D cell cultures and in vivo animal models.

Read More

Why Should You Switch to ELNs?
Why Should You Switch to ELNs?
Blog

Electronic Lab Notebooks (ELNs) are often advertised as the next step in laboratory technology, but uptake has remained stubbornly low despite a wide range of solutions being available on the market. Here, we ask ELN provider labfolder's Co-Founder and CEO Simon Bungers what the industry can do to improve uptake, and how ELNs can answer the question of how to improve data integrity in modern research.

Read More

Students Get Hands-on with Mass Spectrometry
Students Get Hands-on with Mass Spectrometry
Blog

We spoke to Dr Jonathan Jones from Waters Corporation, to learn more about the new initiative that they and Swansea University are leading to give students hands-on experience of mass spectrometry.

Read More

Surface Plasmon Resonance: Driving Better & Faster Decision-making in Drug Discovery
Surface Plasmon Resonance: Driving Better & Faster Decision-making in Drug Discovery
Blog

We recently spoke to Bruker’s JoAnne Bruno, Director Sales and Marketing and Sven Malik, Senior Application Specialist, to learn how surface plasmon resonance can be used to investigate the binding properties of small molecules, and how it can help researchers make better decisions about drug candidates and support efforts to design new molecules.

Read More

NGS Workflows: A Simpler Life Through Software
NGS Workflows: A Simpler Life Through Software
Blog

Having too much data sounds like a nice problem to have. But Next Generation Sequencing (NGS) data’s ubiquity poses challenges as well as opportunities for geneticists. Quick, accurate and reliable workflows are top of the average geneticist’s wishlist. We caught up with OGT’s Dave Cook to discuss the challenges of NGS data, and how software can make things simpler.

Read More

In Vitro Integrity: Maximizing the Value of Plate-Based Assay Data
In Vitro Integrity: Maximizing the Value of Plate-Based Assay Data
Blog

Genedata’s Screener software aims to streamline data workflows and make analysis easier. We caught up with Dr. Oliver Leven, Head of Genedata Screener Business Europe, to discuss how we researchers can make data more standardized, accessible and shareable whilst not compromising on security and integrity.

Read More

Monitoring Pulmonary Exacerbation in Cystic Fibrosis: The Hunt for Urine-based Biomarkers Begins
The Search Begins: Urinary Biomarkers that Indicate Pulmonary Exacerbation in Cystic Fibrosis
Blog

A clinical trial has been launched to identify urine-based biomarkers which indicate lung flare-ups in cystic fibrosis. Researchers believe point-of-care monitoring will help people get treatment faster, improve patient outcomes and reduce healthcare costs.

Read More